OcTagen.com
Title
Octagen Corporation | Developing New Therapies for Hemophilia
Description
Privately held company developing therapies for hemophilia and other genetic disorders, using recombinant Factor VIII and gene therapy. Includes clinical trial status, licensing, corporate profile and contacts in Bala Cynwyd, Pennsylvania.
Contact
| Whois information is public, but in response to some people wanting to keep their contact information private, many domain name Registrars offer a "privacy" or "proxy" service to mask the domain name owner. This domain is most likely using a proxy service. |
Logos
Additional Information
Categories:
- Acquired Hemophilia
- Biopharmaceuticals
- Biotechnology And Pharmaceuticals
- Blood Outgrowth Endothelial Cells
- Business
- Clotting
- Clotting Disorders
- Endothelial Cells
- Factor
- Factor 8
- Factor Viii
- Gene Therapy
- Hemophilia
- Hemophilia A
- Human
- Immunogenic
- Inhibitor Patients
- Inhibitors
- Low Immunogenicity
- Manufacturing
- Pharmaceuticals
- Porcine Factor Viii
- Recombinant
- Recombinant Porcine Factor Viii
- Vii
- Biotechnology and Pharmaceuticals
- Factor VIII
- Porcine Factor VIII
- Recombinant Porcine Factor VIII
- To
- VII